KlausTGottliebMDPhD
Gastroenterology • Santa Maria, CABiliary Tract Disease, Inflammatory Bowel Disease, Pancreas Disease
Klaus Gottlieb, MD
Dr. Gottlieb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1315 South Miller St.
Ste 101
Santa Maria, CA 93454Phone+1 805-349-2945Fax+1 805-349-2887
Summary
- Dr. Klaus Gottlieb is a translational scientist in immunology drug development with American Board certifications in Internal Medicine and Gastroenterology. He holds an MD-PhD (Dr.med.) degree from Bonn University in Germany, an MBA from Indiana University, and a Master of Science in Biotechnology from Johns Hopkins.He was most recently employed at the FDA, Quintiles (IQVIA), and Synthetic Biologics, Inc. He is now a Medical Fellow with Eli Lilly and Company and practices gastroenterology part-time in Santa Maria, CA.
Education & Training
Johns Hopkins UniversityMS, Biotechnology, 2009 - 2012
Indiana University School of MedicineFellowship, Gastroenterology, 1993 - 1995
Loyola University Medical CenterFellowship, Gastroenterology, 1991 - 1993- Loyola University Medical CenterResidency, Internal Medicine, 1988 - 1991
University of Bonn Faculty of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 2016 - 2026
WA State Medical License 1998 - 2024
IL State Medical License 1989 - 1993- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FASGE) American Society for Gastrointestinal Endoscopy
- Fellow (FACP) American College of Physicians, 1995
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy Start of enrollment: 2015 Mar 01
- A Study of the Effect of SYN-010 on Subjects With IBS-C Start of enrollment: 2015 Jun 01
- A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI Start of enrollment: 2015 Oct 01
Publications & Presentations
PubMed
- A feasibility study using quantitative and interpretable histological analyses of celiac disease for automated cell type and tissue area classification.Michael Griffin, Aaron M Gruver, Chintan Shah, Qasim Wani, Darren Fahy
Scientific Reports. 2024-12-02 - 5 citationsCan artificial intelligence replace endoscopists when assessing mucosal healing in ulcerative colitis? A systematic review and diagnostic test accuracy meta-analysis.Alessandro Rimondi, Klaus Gottlieb, Edward J Despott, Marietta Iacucci, Alberto Murino
Digestive and Liver Disease. 2024-07-01 - 3 citationsPathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score an...Aaron M Gruver, Haiyan Lu, Xiaoxian Zhao, Angie D Fulford, Michael D Soper
Diagnostic Pathology. 2023-11-11
Press Mentions
Synthetic Biologics Expands Clinical & Regulatory Leadership Team with Addition of Klaus Gottlieb, MD, FACGJune 2nd, 2015
Promising Celiac Disease Therapies on the HorizonMarch 9th, 2015
Professional Memberships
- Member
- American Institute of Ultrasound in Medicine - AIUMMember
Other Languages
- Spanish, German
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
